195 related articles for article (PubMed ID: 26407221)
1. Glycaemic, blood pressure and cholesterol control in 25 629 diabetics.
Pinchevsky Y; Butkow N; Chirwa T; Raal FJ
Cardiovasc J Afr; 2015; 26(4):188-92. PubMed ID: 26407221
[TBL] [Abstract][Full Text] [Related]
2. Adherence to prescription guidelines and achievement of treatment goals among persons with coronary heart disease in Tromsø 7.
Pedersen E; Garcia BH; Halvorsen KH; Eggen AE; Schirmer H; Waaseth M
BMC Cardiovasc Disord; 2021 Jan; 21(1):44. PubMed ID: 33478404
[TBL] [Abstract][Full Text] [Related]
3. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.
Wens J; Gerard R; Vandenberghe H
Prim Care Diabetes; 2011 Apr; 5(1):19-24. PubMed ID: 21030327
[TBL] [Abstract][Full Text] [Related]
4. Difficulties in reaching therapeutic goals for hypertension and dysplipidaemia in patients with type 2 diabetes in general practice.
Knudsen ST; Mosbech TH; Hansen B; Kønig E; Johnsen PC; Kamper AL
Dan Med J; 2013 Dec; 60(12):A4740. PubMed ID: 24355449
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study.
Leśniak W; Bała MM; Płaczkiewicz-Jankowska E; Topór-Mądry R; Jankowski M; Sieradzki J; Banasiak W;
Cardiol J; 2015; 22(2):150-9. PubMed ID: 25299503
[TBL] [Abstract][Full Text] [Related]
6. Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register.
Karlsson SA; Franzén S; Svensson AM; Miftaraj M; Eliasson B; Andersson Sundell K
BMC Health Serv Res; 2018 Nov; 18(1):900. PubMed ID: 30486824
[TBL] [Abstract][Full Text] [Related]
7. The impact of hospital-diagnosed depression or use of antidepressants on treatment initiation, adherence and HbA
Rohde C; Knudsen JS; Schmitz N; Østergaard SD; Thomsen RW
Diabetologia; 2021 Feb; 64(2):361-374. PubMed ID: 33073329
[TBL] [Abstract][Full Text] [Related]
8. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
[TBL] [Abstract][Full Text] [Related]
9. Variation in the achievement of HbA
Bakke Å; Dalen I; Thue G; Cooper J; Skeie S; Berg TJ; Jenum AK; Claudi T; Fjeld Løvaas K; Sandberg S
Diabet Med; 2020 Sep; 37(9):1471-1481. PubMed ID: 31651045
[TBL] [Abstract][Full Text] [Related]
10. Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries.
Hermans MP; Brotons C; Elisaf M; Michel G; Muls E; Nobels F;
Eur J Prev Cardiol; 2013 Dec; 20(6):1095-105. PubMed ID: 22605788
[TBL] [Abstract][Full Text] [Related]
11. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.
Gyberg V; De Bacquer D; De Backer G; Jennings C; Kotseva K; Mellbin L; Schnell O; Tuomilehto J; Wood D; Rydén L; Amouyel P; Bruthans J; Conde AC; Cifkova R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pająk A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
Cardiovasc Diabetol; 2015 Oct; 14():133. PubMed ID: 26427624
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous control of blood glucose, blood pressure, and lipid among drug-treated Type 2 diabetes patients from Shaanxi province, North-Western China: A multicenter study.
Xu S; Sun F; Xu W; Jiao K; Shi B; Xie X; Wang Y; Zhu M; Ji Q
Niger J Clin Pract; 2016; 19(6):784-792. PubMed ID: 27811452
[TBL] [Abstract][Full Text] [Related]
13. Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: insights from the Associazione Medici Diabetologi Annals initiative.
De Cosmo S; Viazzi F; Pacilli A; Giorda C; Ceriello A; Gentile S; Russo G; Rossi MC; Nicolucci A; Guida P; Di Bartolo P; Pontremoli R;
Nephrol Dial Transplant; 2015 Sep; 30(9):1526-33. PubMed ID: 25883195
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the assessment and management of cardiometabolic risk in patients with and without type 2 diabetes mellitus in Canadian primary care.
Teoh H; Després JP; Dufour R; Fitchett DH; Goldin L; Goodman SG; Harris SB; Langer A; Lau DC; Lonn EM; Mancini GB; McFarlane PA; Poirier P; Rabasa-Lhoret R; Tan MK; Leiter LA
Diabetes Obes Metab; 2013 Dec; 15(12):1093-100. PubMed ID: 23683111
[TBL] [Abstract][Full Text] [Related]
15. What matters in ADVANCE and ADVANCE-ON.
Hamet P
Diabetes Obes Metab; 2012 Jan; 14 Suppl 1():20-9. PubMed ID: 22118707
[TBL] [Abstract][Full Text] [Related]
16. ["Diabetes in Germany"(DIG) study. A prospective 4-year-follow-up study on the quality of treatment for type 2 diabetes in daily practice].
Ott P; Benke I; Stelzer J; Köhler C; Hanefeld M
Dtsch Med Wochenschr; 2009 Feb; 134(7):291-7. PubMed ID: 19197810
[TBL] [Abstract][Full Text] [Related]
17. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification.
Schmittdiel JA; Uratsu CS; Karter AJ; Heisler M; Subramanian U; Mangione CM; Selby JV
J Gen Intern Med; 2008 May; 23(5):588-94. PubMed ID: 18317847
[TBL] [Abstract][Full Text] [Related]
18. Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study.
Itoh H; Komuro I; Takeuchi M; Akasaka T; Daida H; Egashira Y; Fujita H; Higaki J; Hirata KI; Ishibashi S; Isshiki T; Ito S; Kashiwagi A; Kato S; Kitagawa K; Kitakaze M; Kitazono T; Kurabayashi M; Miyauchi K; Murakami T; Murohara T; Node K; Ogawa S; Saito Y; Seino Y; Shigeeda T; Shindo S; Sugawara M; Sugiyama S; Terauchi Y; Tsutsui H; Ueshima K; Utsunomiya K; Yamagishi M; Yamazaki T; Yo S; Yokote K; Yoshida K; Yoshimura M; Yoshimura N; Nakao K; Nagai R;
Diabetes Obes Metab; 2019 Apr; 21(4):791-800. PubMed ID: 30393955
[TBL] [Abstract][Full Text] [Related]
19. Community-Based Intervention to Improve Cardiometabolic Targets in Patients With Stroke: A Randomized Controlled Trial.
Olaiya MT; Cadilhac DA; Kim J; Nelson MR; Srikanth VK; Gerraty RP; Bladin CF; Fitzgerald SM; Phan T; Frayne J; Thrift AG
Stroke; 2017 Sep; 48(9):2504-2510. PubMed ID: 28754834
[TBL] [Abstract][Full Text] [Related]
20. Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients' risk level.
Roccatagliata D; Avanzini F; Monesi L; Caimi V; Lauri D; Longoni P; Marchioli R; Tombesi M; Tognoni G; Roncaglioni MC;
Vasc Health Risk Manag; 2006; 2(4):507-14. PubMed ID: 17323606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]